Brief: Valbiotis Announces Positive Preclinical Results For Totum-63

Valbiotis SA

06/12/2017 16:36

Dec 6 (Reuters) - VALBIOTIS SAS  ALVAL.PA : 
    * VALBIOTIS ANNOUNCES POSITIVE PRECLINICAL RESULTS FOR 
TOTUM-63, 
THE ACTIVE INGREDIENT IN VAL-63-NAFLD, FOR NON-ALCOHOLIC FATTY 
LIVER (NAFL), A RISK FACTOR FOR NASH 
    * SHARP 40% REDUCTION IN HEPATIC TRIGLYCERIDES IN 
PRECLINICAL 
PHASE, IMPROVEMENT OF RELATED METABOLIC PARAMETERS 
    * CONFIRMATION OF POSITIVE DATA ALREADY OBTAINED IN DIABETIC 
MODELS 
 
Source text for Eikon:  ID:nBw4j831Ga  
Further company coverage:  ALVAL.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))